These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7534313)

  • 1. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells.
    Yang B; Hall CL; Yang BL; Savani RC; Turley EA
    J Cell Biochem; 1994 Dec; 56(4):455-68. PubMed ID: 7534313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
    Turley EA; Austen L; Moore D; Hoare K
    Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM.
    Turley EA; Hossain MZ; Sorokan T; Jordan LM; Nagy JI
    Glia; 1994 Sep; 12(1):68-80. PubMed ID: 7531178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
    Yang B; Yang BL; Savani RC; Turley EA
    EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM.
    Yang B; Zhang L; Turley EA
    J Biol Chem; 1993 Apr; 268(12):8617-23. PubMed ID: 7682552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
    Teder P; Bergh J; Heldin P
    Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM.
    Hall CL; Lange LA; Prober DA; Zhang S; Turley EA
    Oncogene; 1996 Nov; 13(10):2213-24. PubMed ID: 8950989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity.
    Hall CL; Wang C; Lange LA; Turley EA
    J Cell Biol; 1994 Jul; 126(2):575-88. PubMed ID: 7518470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.
    Samuel SK; Hurta RA; Spearman MA; Wright JA; Turley EA; Greenberg AH
    J Cell Biol; 1993 Nov; 123(3):749-58. PubMed ID: 7693717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells.
    Pilarski LM; Miszta H; Turley EA
    J Immunol; 1993 May; 150(10):4292-302. PubMed ID: 7683315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new polyclonal antibody that recognizes a human receptor for hyaluronan mediated motility.
    Kuwabara H; Yoneda M; Nagai M; Hayasaki H; Mori H
    Cancer Lett; 2004 Jul; 210(1):73-80. PubMed ID: 15172123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
    Singleton PA; Bourguignon LY
    Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis.
    Xu XM; Chen Y; Chen J; Yang S; Gao F; Underhill CB; Creswell K; Zhang L
    Cancer Res; 2003 Sep; 63(18):5685-90. PubMed ID: 14522884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased connexin-43 and gap junctional communication correlate with altered phenotypic characteristics of cells overexpressing the receptor for hyaluronic acid-mediated motility.
    Nagy JI; Hossain MZ; Lynn BD; Curpen GE; Yang S; Turley EA
    Cell Growth Differ; 1996 Jun; 7(6):745-51. PubMed ID: 8780888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
    Zhu D; Bourguignon LY
    Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.